Identification and chromosomal location of two human genes encoding enzymes potentially involved in proteolytic maturation of farnesylated proteins

Genomics

Volumn 58, Issue 3, 1999, Pages 270-280

  Freije, José M P ^a   Blay, Pilar ^a   Pendás, Alberto M ^a   Cadiñanos, Juan ^a   Crespo, Piero ^b   López Otín, Carlos ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

A factor; Metalloproteases; Oncogenes; Prenylation; Ras

Indexed keywords

FACTOR A; MEMBRANE PROTEIN; METALLOPROTEINASE; PHEROMONE; RAS PROTEIN;

ARTICLE; CANCER GENETICS; CARCINOMA; CHROMOSOMAL LOCALIZATION; CHROMOSOME 11Q; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE LIBRARY; GENE MAPPING; HOUSEKEEPING GENE; HUMAN; LYMPHOMA; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRENYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TISSUE DISTRIBUTION;

EID: 0033564670     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1999.5834     Document Type: Article

References (34)

1. Ashby M. N., King D. S., Rine J. Endoproteolytic processing of a farnesylated peptide in vitro. Proc. Natl. Acad. Sci. USA. 89:1992;4613-4617.
2. Barbacid M. ras genes. Annu. Rev. Biochem. 56:1987;779-827.
3. Barrington R. E., Subler M. A., Rands E., Omer C. A., Miller P. J., Hundley J. E., Koester S. K., Troyer D. A., Bearss D. J., Conner M. W., Gibbs J. B., Hamilton K., Koblan K. S., Mosser S. D., O'Neill T. J., Schaber M. D., Senderak E. T., Windle J. J., Oliff A., Kohl N. E. A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis. Mol. Cell. Biol. 18:1998;85-92.
4. Bos J. L. ras oncogenes in human cancer: A review. Cancer Res. 49:1989;4682-4689.
5. Boyartchuk V. L., Ashby M. N., Rine J. Modulation of Ras and a-factor function by carboxyl-terminal proteolysis. Science. 275:1997;1796-1800.
6. Chen Y., Ma Y. T., Rando R. R. Solubilization, partial purification, and affinity labeling of the membrane-bound isoprenylated protein endoprotease. Biochemistry. 35:1996;3227-3237.
7. Clarke S. Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Annu. Rev. Biochem. 61:1992;355-386.
8. Dai Q., Choy E., Chiu V., Romano J., Slivka S. R., Steitz S. A., Michaelis S., Philips M. R. Mammalian prenylcysteine carboxyl methyltransferase is in the endoplasmic reticulum. J. Biol. Chem. 273:1998;15030-15034.
9. Devereux J., Haeberli P., Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:1984;387-395.
10. 2-terminal processing of the yeast a-factor precursor. J. Cell Biol. 136:1997;271-285.
11. Gyapay G., Schmitt K., Fizames C., Jones H., Vega Czarny N., Spillett D., Muselet D., PrudHomme J. F., Dib C., Auffray C., Morissette J., Weissenbach J., Goodfellow P. N. A radiation hybrid map of the human genome. Hum. Mol. Genet. 5:1996;339-346.
12. Hancock J. F., Cadwallader K., Marshall C. J. Methylation and proteolysis are essential for efficient membrane binding of prenylated p21K-ras(B). EMBO J. 10:1991;641-646.
13. Hooper N. M. Families of zinc metalloproteases. FEBS Lett. 354:1994;1-6.
14. Hrycyna C. A., Clarke S. Maturation of isoprenylated proteins in Saccharomyces cerevisiae: Multiple activities catalyze the cleavage of the three carboxyl-terminal amino acids from farnesylated substrates in vitro. J. Biol. Chem. 267:1992;10457-10464.
15. Jang G. F., Gelb M. H. Substrate specificity of mammalian prenyl protein-specific endoprotease activity. Biochemistry. 37:1998;4473-4481.
16. Jang G. F., Yokoyama K., Gelb M. H. A prenylated protein-specific endoprotease in rat liver microsomes that produces a carboxyl-terminal tripeptide. Biochemistry. 32:1993;9500-9507.
17. Lebowitz P. F., Sakamuro D., Prendergast G. C. Farnesyl transferase inhibitors induce apoptosis of Ras-transformed cells denied substratum attachment. Cancer Res. 57:1997;708-713.
18. Lerner E. C., Zhang T. T., Knowles D. B., Qian Y., Hamilton A. D., Sebti S. M. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines. Oncogene. 15:1997;1283-1288.
19. Lowy D. R., Willumsen B. M. Function and regulation of ras. Annu. Rev. Biochem. 62:1993;851-891.
20. Ma Y. T., Rando R. R. A microsomal endoprotease that specifically cleaves isoprenylated peptides. Proc. Natl. Acad. Sci. USA. 89:1992;6275-6279.
21. Mangues R., Corral T., Kohl N. E., Symmans W. F., Lu S., Malumbres M., Gibbs J. B., Oliff A., Pellicer A. Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice. Cancer Res. 58:1998;1253-1259.
22. Mitelman F., Mertens F., Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nature Genet. 15:1997;417-474.
23. Pendás A. M., Matilla T., Uría J. A., Freije J. P., Fueyo A., Estivill X., López-Otín C. Mapping of the human Zn-alpha 2-glycoprotein gene (AZGP1) to chromosome 7q22 by in situ hybridization. Cytogenet. Cell Genet. 66:1994;263-266.
24. Rawlings N. D., Barrett A. J. Evolutionary families of metallopeptidases. Methods Enzymol. 248:1995;183-228.
25. Rawson R. B., Zelenski N. G., Nijhawan D., Ye J., Sakai J., Hasan M. T., Chang T. Y., Brown M. S., Goldstein J. L. Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. Mol. Cell. 1:1997;47-57.
26. Sapperstein S., Berkower C., Michaelis S. Nucleotide sequence of the yeast STE14 gene, which encodes farnesylcysteine carboxyl methyltransferase, and demonstration of its essential role in a-factor export. Mol. Cell. Biol. 14:1994;1438-1449.
27. Schuuring E., Verhoeven E., van Tinteren H., Peterse J. L., Nunnink B., Thunnissen F. B., Devilee P., Cornelisse C. J., van de Vijver M. J., Mooi W. J., Rob J. A., Michalides J. A. M. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res. 52:1992;5229-5234.
28. Shearman A. M., Hudson T. J., Andresen J. M., Wu X., Sohn R. L., Haluska F., Housman D. E., Weiss J. S. The gene for Schnyder's crystalline corneal dystrophy maps to human chromosome 1p34.1-p36. Hum. Mol. Genet. 5:1996;1667-1672.
29. 2-terminal proteolysis and COOH-terminal CAAX processing. J. Cell Biol. 142:1998;635-649.
30. Tsuda H., Hirohashi S., Shimosato Y., Hirota T., Tsugane S., Yamamoto H., Miyajima N., Toyoshima K., Yamamoto T., Yokota J., Yoshida T., Sakamoto H., Terada M., Sugimura T. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. Cancer Res. 49:1989;3104-3108.
31. Van Camp G., Coucke P. J., Kunst H., Schatteman I., Van Velzen D., Marres H., van Ewijk M., Declau F., Van Hauwe P., Meyers J., Kenyon J., Smith S. D., Smith R. J., Djelantik B., Cremers C. W., Van de Heyning P. H., Willems P. J. Linkage analysis of progressive hearing loss in five extended families maps the DFNA2 gene to a 1.25-Mb region on chromosome 1p. Genomics. 41:1997;70-74.
32. Van Damme H., Brok H., Schuuring-Scholtes E., Schuuring E. The redistribution of cortactin into cell-matrix contact sites in human carcinoma cells with 11q13 amplification is associated with both overexpression and post-translational modification. J. Biol. Chem. 272:1997;7374-7380.
33. Williams T. A., Corvol P., Soubrier F. Identification of two active site residues in human angiotensin I-converting enzyme. J. Biol. Chem. 269:1994;29430-29434.
34. Zhang F. L., Casey P. J. Protein prenylation: Molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65:1996;241-269.